QPS Taiwan Awarded GLP-Laboratory Certification by DOH, Taiwan
Newark, DE
QPS, a leading GLP/GCP‑compliant contract research organization providing testing services to support preclinical and clinical research and development, announced today that QPS Taiwan, its Asian operation, has been awarded a Good Laboratory Practice (GLP)‑laboratory certification by the Department of Health (DOH), Executive Yuan, R.O.C. (Taiwan). QPS received this certification due to their exceptional track record and scientific infrastructure, including global Standard Operating Procedures (SOPs), understanding of the regulatory agency of requirement, and planning for the implementation of systems and processes within the Taiwan facility.
“QPS Taiwan has been awarded the first and only GLP-laboratory certification by DOH, Taiwan for bioanalytical services supporting preclinical and clinical research,” stated QPS Taiwan President and CEO, Vincent Yen, M.B.A. “QPS Taiwan shares the same criteria, global SOPs, laboratory procedures, equipment (API 4000 triple quadrupole mass spectrometers, Shimadzu VP-series LCs, Tomtec Quadra), laboratory operations (Rees Monitors, Watson LIMS systems), and systems and processes as QPS U.S.A. We are excited about this certification..."
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.
